Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pacira BioSciences Inc.

www.pacira.com

Latest From Pacira BioSciences Inc.

US FDA, Advisory Committees Rarely Disagree

A Milbank Quarterly study and a Pink Sheet analysis show that disagreement between the US FDA and its advisory committee meetings doesn't happen often; it is even rarer for the agency to approve a drug against the advice from a panel.
Advisory Committees Approvals

Time To Spare? US FDA “Opioid-Sparing” Guidance May Take Longer Than Expected

In August, it sounded like FDA was almost ready to issue guidance on “opioid-sparing” claims for acute pain treatments. After a November advisory committee meeting, that doesn’t seem to be the case.
Drug Approval Standards Neurology

Opioid-Sparing Claims May Be Better Suited For Phase IV Trials Instead Of Phase III

US FDA advisory committee panelists argue that prospective, randomized Phase III trials fail to reflect real-world treatment decisions.

Advisory Committees Neurology

US FDA Faced With Suite Of Opinions Defining 'Clinically Meaningful' Opioid-Sparing Claims

Advisory committee agreed that statistically significant reduction in average opioid use and decrease in absolute amount were insufficient components on their own; a decrease in duration of use and a decrease in the amount of patients who don't need opioids received some support.
Advisory Committees Neurology
See All

Company Information

  • Industry
  • Biotechnology
    • Liposomes
  • Medical Devices
    • Surgical Equipment & Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Cancer
  • Dermatology
  • Neurology, Nervous System
  • Alias(es)
  • DepoTech Corp.
  • SkyePharma Inc.
  • Pacira Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pacira BioSciences Inc.
  • Senior Management
  • David M Stack, Pres. & CEO
    Charles A Reinhard, III, CFO
    Charles Laranjeira, CTO
    Richard B Scranton, MD, CMO
    Dennis McLoughlin, Chief Commercial Officer
  • Contact Info
  • Pacira BioSciences Inc.
    Phone: (973) 254-3560
    5 Sylvan Way
    Ste. 300
    Parsippany, NJ 07054
    USA
UsernamePublicRestriction

Register